| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 08/06/2013 | US8501768 Hexahydrocyclopentapyrrolone, hexahydropyrrolopyrrolone, octahydropyrrolopyridinone and octahydropyridinone compounds |
| 08/06/2013 | US8501713 Drug combinations for the treatment of duchenne muscular dystrophy |
| 08/06/2013 | CA2591937C Tetralin and indane derivatives and uses thereof |
| 08/06/2013 | CA2557304C Ketoamides with cyclic p4's as inhibitors of ns3 serine protease of hepatitis c virus |
| 08/06/2013 | CA2525447C Amphiphilic trisulfonated porphyrazines for photodynamic applications in medicine |
| 08/01/2013 | WO2013112878A1 Mcl-1 modulating compositions |
| 08/01/2013 | WO2013111713A1 Carbazole polymer |
| 08/01/2013 | US20130197053 Pharmaceutical composition containing a tryptophan derivative |
| 08/01/2013 | US20130197052 Tryptamine derivatives, their preparation and their use in gastropathy |
| 08/01/2013 | US20130197026 Composition and methods for treating glioblastoma |
| 08/01/2013 | US20130197011 Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament |
| 08/01/2013 | US20130196978 Alkaloid aminoester derivatives and medicinal composition thereof |
| 08/01/2013 | US20130196050 Salty taste enhancer |
| 08/01/2013 | US20130192978 Photoacid compositions having extended lifetime of proton dissociation state |
| 07/31/2013 | EP2620429A1 Hydroxylamine compounds and methods of their use |
| 07/31/2013 | EP2619179A1 Matrix metalloproteinase inhibitors |
| 07/31/2013 | EP2619178A1 Substituted benzamide compounds |
| 07/31/2013 | CN103228661A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 07/31/2013 | CN103224474A Synthesis of tetracyclines and analogues thereof |
| 07/31/2013 | CN103224463A Purpose of benzo indolium containing compound LTH02 in treating multi-drug resistant bacterial infection diseases |
| 07/31/2013 | CN103224462A N-phenyl phthalimide synthesis method |
| 07/31/2013 | CN103224437A Amino acid methyl ester hydrochloride preparation |
| 07/31/2013 | CN102060643B Preparation method of N-aryl amino acid |
| 07/31/2013 | CN102030683B Sitagliptin intermediate and preparation method and application thereof |
| 07/30/2013 | US8497297 Dimeric IAP inhibitors |
| 07/30/2013 | US8497295 Spiroindoline modulators of muscarinic receptors |
| 07/30/2013 | CA2601647C An improved process for the purification of perindopril |
| 07/30/2013 | CA2583973C Aminomethyl substituted bicyclic aromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 07/25/2013 | WO2013110005A1 Boronate-mediated delivery of molecules into cells |
| 07/25/2013 | WO2013109859A1 Dye compositions, methods of preparation, conjugates thereof, and methods of use |
| 07/25/2013 | WO2013109045A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 07/25/2013 | WO2013109011A1 Novel cyanine derivatives having meso-reactive functional group at polymethine chain and preparation method thereof |
| 07/25/2013 | WO2013107283A1 Benzoheterocyclic compounds and use thereof |
| 07/25/2013 | US20130190488 Apoptosis promoters |
| 07/25/2013 | US20130190407 Calcium receptor-active molecules |
| 07/25/2013 | US20130190371 Fungicide Active Substance Combinations |
| 07/25/2013 | US20130190339 Pro-Neurogenic Compounds |
| 07/25/2013 | US20130190296 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 07/25/2013 | US20130190273 Methods for Treating Amyotrophic Lateral Sclerosis Using Pro-Neurogenic Compounds |
| 07/25/2013 | US20130188270 Oxime ester |
| 07/24/2013 | EP2617712A1 Nitrogen-containing aromatic heterocyclic derivative and organic electroluminescence device using same |
| 07/24/2013 | EP2616440A1 Arylosulfonamides for the treatment of cns diseases |
| 07/24/2013 | EP2616439A1 Tryptamine derivatives, their preparation and their use in gastropathy |
| 07/24/2013 | CN1780897B Novel materials for electroluminescence |
| 07/24/2013 | CN103221391A Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof |
| 07/24/2013 | CN103214412A Polycyclic derivative with chiral spiral oxoindole structure segment and synthetic method of polycyclic derivative |
| 07/24/2013 | CN103214411A Preparation method of fullerene microsphere with crinkly surface |
| 07/24/2013 | CN103214410A Series of asymmetrical squarine micromolecules as well as preparation method and application thereof |
| 07/24/2013 | CN103214409A Synthesis of tetracyclines and analogues thereof |
| 07/24/2013 | CN103214408A Method for synthesizing bisindole methane derivative |
| 07/24/2013 | CN103214394A Alkynyl imine derivative |
| 07/24/2013 | CN103214376A Substituted 4-aminocyclohexane derivatives |
| 07/24/2013 | CN103214337A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 07/24/2013 | CN103214327A Aromatic ring or heteroaromatic trifluoromethyl ketone compound and preparation method thereof |
| 07/24/2013 | CN102627631B Benzoheterocycle compound and preparation method as well as medical application thereof |
| 07/24/2013 | CN102093341B Indole ring substituted pyrazole carboxylic acid endothelin receptor antagonist as well as preparation method and application thereof |
| 07/24/2013 | CN101863794B 3'-alkoxy spirocyclische tetramic and tetronic acids |
| 07/24/2013 | CN101792422B Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 07/24/2013 | CN101503373B 2-amino-1-(4-nitro phenyl)-1-ethanol metalloid protease inhibitor, and preparation and use thereof |
| 07/24/2013 | CN101405264B Piperidinyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases |
| 07/23/2013 | US8492560 Quinazoline derivatives as angiogenesis inhibitors |
| 07/23/2013 | US8492559 Substituted indole compounds |
| 07/23/2013 | US8492428 Small-molecule botulinum toxin inhibitors |
| 07/23/2013 | US8492427 Isoindolones derivatives as MEK kinase inhibitors and methods of use |
| 07/23/2013 | CA2664004C Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
| 07/23/2013 | CA2616396C Growth hormone secretagogues |
| 07/23/2013 | CA2599348C Indole compound and use thereof |
| 07/18/2013 | WO2013106460A2 Compositions and methods for treating malignant astrocytomas |
| 07/18/2013 | WO2013106349A1 Use of the aminoalkylindole jwh-073-m4 and related compounds as neutral cb1 recptor antagonists for the treatment of alcoholism, drug abuse, obesity, and obesity-related diseases |
| 07/18/2013 | US20130184463 Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response |
| 07/18/2013 | US20130184301 Methods of Treating Post-Traumatic Stress Disorder Using Pro-Neurogenic Compounds |
| 07/18/2013 | US20130184300 Methods of Treating Traumatic Brain Injury Using Pro-Neurogenic Compounds |
| 07/18/2013 | US20130184276 Modulators of atp-binding cassette transporters |
| 07/18/2013 | US20130184275 Hydrazone modulators of cannabinoid receptors |
| 07/18/2013 | US20130184271 Methods for Treating Parkinson's Disease Using Pro-Neurogenic Compounds |
| 07/18/2013 | US20130184262 Diaminocyclohexane compounds and uses thereof |
| 07/18/2013 | US20130184258 Compositions Useful as Inhibitors of Voltage-Gated Sodium Channels |
| 07/17/2013 | EP2614051A2 P53-mdm2 antagonists |
| 07/17/2013 | CN103210044A Azo dye, ocular lens material, method for producing ocular lens material, and ocular lens |
| 07/17/2013 | CN103204960A Novel tertiary-amine oxime ester photoinitiator and preparation method thereof |
| 07/17/2013 | CN103204846A Carbazole derivative, organic electroluminescent device thereof, and manufacturing method of device |
| 07/17/2013 | CN103204798A Aromatic amine derivative, its preparation method and organic electroluminescent device made through using it |
| 07/17/2013 | CN103204797A Arylamine organic luminescence material of dihydropentacene, and preparation method thereof |
| 07/17/2013 | CN103204796A Dibenzo[c,g]carbazole Compound, Light-emitting Element, Light-emitting Device, Display Device, Lighting Device And Electronic Device |
| 07/17/2013 | CN102241620B Benzo(9,10)phenanthryl-containing aromatic compounds and organic light emitting diode using same |
| 07/17/2013 | CN102175786B Aminopropanol derivatives |
| 07/17/2013 | CN101450907B Processes for the preparation of glutamic acid compounds intermediates and novel intermediates used in the processes |
| 07/16/2013 | US8487018 Heavy metal-free and anaerobically compostable vinyl halide compositions, articles and landfill biodegradation |
| 07/16/2013 | US8486990 SirT inhibitors that bind to NAD |
| 07/16/2013 | US8486989 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 07/16/2013 | US8486984 Aminomethyl substituted bicyclic aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| 07/16/2013 | US8486943 Tetrahydrocyclopenta[b]indole androgen receptor modulators |
| 07/16/2013 | CA2577222C Isoindoline compounds and methods of making and using the same |
| 07/16/2013 | CA2514988C Sulfonic acids, their derivatives and pharmaceutical compositions containing them |
| 07/11/2013 | WO2013102741A1 Delta-crystalline form of perindopril arginine salt, preparation method thereof, and pharmaceutical compositions containing same |
| 07/11/2013 | WO2013102740A1 Method for the preparation of perindopril arginine salt |
| 07/11/2013 | WO2013102634A1 Method for preparation of octahydrocyclopenta[c]pyrrole |
| 07/11/2013 | WO2013102242A1 Heterocyclic compounds and methods for their use |
| 07/11/2013 | WO2013019079A3 Composition containing 5-hydroxyindole compounds or sponge scalarispongia sp. extracts as active ingredients for prevention and treatment of cancer diseases |
| 07/11/2013 | WO2012049688A8 An improved process for the preparation of racemic 6, 6- dimethyl-3-azabicyclo-[3.1.0]-hexane and its salts, a key raw material for hcv inhibitor. |